Cytochrome P-450 CYP2C9 Inhibitors (strong)
- Name
- Cytochrome P-450 CYP2C9 Inhibitors (strong)
- Accession Number
- DBCAT002635
- Description
Not Available
- Drugs
Drug Drug Description Nicardipine A calcium channel blocker used for the short-term treatment of hypertension and chronic stable angina. Delavirdine A non-nucleoside reverse transcriptase inhibitor used to treat HIV infection. Gemfibrozil A lipid regulator that is used in the reduction of serum triglyceride levels in high-risk patients with hyperlipidemia. Capecitabine A nucleoside metabolic inhibitor indicated to treat different gastrointestinal, including pancreatic cancer, and breast cancer. Floxuridine An antimetabolite used as palliative management for liver metastases of gastrointestinal malignancy. Curcumin No approved therapeutic indications. Miconazole An azole antifungal with broad-spectrum activity used to treat fungal infections affecting the vagina, mouth and skin, including candidiasis. Sulfaphenazole For the treatment bacterial infections. Sorafenib A kinase inhibitor used to treat unresectable liver carcinoma, advanced renal carcinoma, and differentiated thyroid carcinoma. Clotrimazole A topical broad-spectrum antifungal agent used for the treatment of a wide variety of dermatophyte infections and candidiasis. Fluconazole A triazole antifungal used to treat various fungal infections including candidiasis. Tepotinib An oral tyrosine kinase inhibitor targeted against MET for the treatment of metastatic non-small cell lung cancer in patients exhibiting MET exon 14 skipping mutations. - Drugs & Drug Targets